AAC
Home Help [Feedback] [For Subscribers] [Archive] [Search] --
AAC Accepts, published online ahead of print on 12 March 2007
This Article
Right arrow Full Text (PDF)
Right arrow Other Versions of this Article:
AAC.01432-06v1
51/5/1687    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Hsu, C.-H.
Right arrow Articles by Cheng, Y.-C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Hsu, C.-H.
Right arrow Articles by Cheng, Y.-C.

 Previous Article  |  Next Article 

Antimicrob. Agents Chemother. doi:10.1128/AAC.01432-06
Copyright (c) 2007, American Society for Microbiology and/or the Listed Authors/Institutions. All Rights Reserved.

Comparison of Phosphorylation of 4'-Ethynyl 2',3'-dihydro-3'-deoxythymidine with Other Anti-HIV Thymidine Analogs

Chih-Hung Hsu, Rong Hu, Ginger E. Dutschman, Guangwei Yang, Preethi Krishnan, Hiromichi Tanaka, Masanori Baba, and Yung-Chi Cheng*

Department of Pharmacology, Yale University School of Medicine, New Haven, Connecticut 06520, USA; School of Pharmaceutical Sciences, Showa University, Tokyo 142-8555, Japan; Center for Chronic Viral Diseases, Division of Antiviral Chemotherapy, Faculty of Medicine, Kagoshima University, Kagoshima 890-8520, Japan; Department of Oncology, National Taiwan University Hospital, Taipei, Taiwan

* To whom correspondence should be addressed. Email: yccheng{at}yale.edu.


   Abstract

Thymidine analogs, including 3'-azido-3'-deoxythymidine (AZT) and 2',3'-dideoxy-3'-deoxythymidine (D4T), are important anti-retroviral agents. To exert anti-retroviral activity, these analogs undergo a stepwise phosphorylation intracellularly to the active triphosphate metabolites. We previously reported that 4'-substituted D4T with an ethynyl group (i.e., 4'-ethynyl D4T) increased the anti-HIV activity and was active against multi-drug resistant HIV strains. 4'-Ethynyl D4T is a better substrate for phosphorylation by human thymidine kinase 1 than D4T. In this report, we first studied the enzymes involved in the phosphorylation of 4'-ethynyl D4T from monophosphate (MP) to triphosphate (TP) metabolites. The 4'-ethynyl D4TMP is phosphorylated by recombinant human TMP kinase with a Km 19 ± 4 µM and a kcat 0.007 ± 0.001 sec-1; the relative efficiency is about 9% and 15% of that of D4TMP and AZTMP, respectively. Several enzymes from crude cellular extracts, including nucleoside diphosphate kinase, pyruvate kinase, creatine kinase and 3-phosphoglycerate kinase, could phosphorylate 4'-ethynyl D4T-diphosphate (DP). The relative phosphorylation efficiencies of 4'-ethynyl D4TDP were 3~ 25% of those of D4TDP, and were generally similar to those of AZTDP. In T-lymphoid cells lines, there was preponderant accumulation of 4'-ethynyl D4TMP, suggesting that TMP kinase could be the rate-limiting enzyme in the metabolism of 4'-ethynyl D4T. Although the same enzymes are involved in the stepwise phosphorylation of thymidine analogs, their behaviors in phosphorylating metabolites of 4'-ethynylD4T are different from those of D4T and AZT. Qualitatively, the metabolism of 4'-ethynyl D4T is more similar to that of AZT than to its progenitor, D4T.




This article has been cited by other articles:




Home Help [Feedback] [For Subscribers] [Archive] [Search] --
Clin. Vaccine Immunol. Clin. Microbiol. Rev.
J. Clin. Microbiol. ALL ASM JOURNALS

Copyright © 2007 by the American Society for Microbiology. All rights reserved.